why choose us

First received: February 24, 2023

Clinical Trial: A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Esophageal Carcinoma

Study Type: OBSERVATIONAL


Official Title: Prospective Evaluation of Nivolumab in Adjuvant Esophageal Carcinoma/Gastroesophageal Junction Carcinoma: A Non-interventional Study

Brief Summary: The purpose of this study is to describe the effectiveness and use of nivolumab after surgery in participants with early stage (Stage II/III) Esophageal Cancer/Gastroesophageal Junction Cancer (EC/GEJC).

Read more